NCT06352515Not yet recruiting
T Lymphocyte Subsets in Ulcerative Colitis
Peripheral Blood T Lymphocyte Subsets in Ulcerative Colitis
Source: ClinicalTrials.gov · Last updated 29 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
1. Study the distribution of peripheral blood T lymphocyte subsets among ulcerative colitis patients. 2. Correlation of T-cell subsets to therapeutic response/ disease activity. 3. Assess the value of circulating IgG anti-Integrin αvβ6 in UC.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 80 (estimated)
- First submitted
- 2 Apr 2024
- Start date
- 1 Jun 2024
- Primary completion date
- 1 Jun 2026
- Lead sponsor
- Assiut University
- Diseases
- Ulcerative colitis
- NCT number
- NCT06352515
What you commit to
- Study type: Observational
- Planned participants: 80
- From 1 Jun 2024 to the primary completion date, 1 Jun 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients who have other autoimmune disease.
Age
- Age \<18 years old.
Other
- Patients who refuse to participate in the study.
Who the study is looking for
- patients with clinical diagnosis of ulcerative colitis among both sexes.
- Age \>18 years Old.
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.